LFA
AVNS

LGT Financial Advisors’s Avanos Medical AVNS Stock Holding History

LGT Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-39
Closed -$621 – 338
2024
Q4 		$621 Hold
39
– – ﹤0.01% 691
2024
Q3 		$937 Hold
39
– – ﹤0.01% 673
2024
Q2 		$777 Sell
39
-100
-72% -$1.95K ﹤0.01% 749
2024
Q1 		$2.77K Hold
139
– – ﹤0.01% 723
2023
Q4 		$3.12K Hold
139
– – ﹤0.01% 717
2023
Q3 		$2.81K Buy
+139
New +$3.15K ﹤0.01% 740

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LGT Financial Advisors's AVNS Position: Q1 2025 in Review

LGT Financial Advisors sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 39 shares — an estimated $621 sold.

LGT Financial Advisors first reported a position in AVNS in Q3 2023 and held it in 6 quarters. The position peaked at $3.12K in Q4 2023. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

  • LGT Financial Advisors reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 39 Avanos Medical shares in Q1 2025, an estimated $621.
  • LGT Financial Advisors first reported a position in Avanos Medical in Q3 2023 and held it in 6 quarters.
  • LGT Financial Advisors's Avanos Medical position peaked at $3.12K in Q4 2023.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on LGT Financial Advisors's 13F filing for Q1 2025, filed 8 May 2025.